TELA Bio (TELA) Other Operating Expenses (2018 - 2026)

TELA Bio's Other Operating Expenses history runs 9 years deep, the most recent figure standing at $204000.0 for Q1 2026.

• On a quarterly basis, Other Operating Expenses fell 68.85% year-over-year to $204000.0 in Q1 2026; TTM through Mar 2026 was -$41.1 million, a 6566.93% decrease from a year earlier, with the FY2025 full-year figure at $987000.0, down 86.98% from the prior year.
• Other Operating Expenses rose to $204000.0 in Q1 2026 per TELA's latest filing, from -$41.6 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $14.6 million in Q2 2023 and bottomed at -$41.6 million in Q4 2025.
• The 5-year median for Other Operating Expenses is $2.4 million (2023), against an average of $1.7 million.
• Across the five-year window, Other Operating Expenses surged 692.9% in 2022 and sank 100.14% in 2024, its largest moves.
• Year by year, Other Operating Expenses stood at $2.7 million in 2022, then decreased by 1.5% to $2.7 million in 2023, then tumbled by 100.74% to -$20000.0 in 2024, then tumbled by 207680.0% to -$41.6 million in 2025, then soared by 100.49% to $204000.0 in 2026.
• Per Business Quant, the three latest TELA Other Operating Expenses figures stand at $204000.0 (Q1 2026), -$41.6 million (Q4 2025), and $242000.0 (Q3 2025).